Restrictive Atrial Septum Defect Becomes a Risk Factor for Norwood Palliation of Hypoplastic Left Heart Syndrome Only When It Is Combined with Mitral or Aortic Atresia

Abstract

Background Restrictive atrial septal defect (ASD) is described as risk factor for Norwood procedure because of elevated pulmonary resistance. We hypothesized that it invariably could not cause pulmonary hypertension, unless it was combined with mitral valve or aortic valve atresia. We investigated how restrictive ASD influenced survival of patients with hypoplastic left heart syndrome (HLHS) who underwent Norwood operation.

Patients and Methods A total of 118 HLHS patients who underwent surgery between January 2005 and December 2012 were grouped into three groups. Group 1 included 31 patients with restrictive ASD combined with mitral or aortic atresia; Group 2 composed of 12 patients with restrictive ASD and mitral and aortic stenosis; Group 3 (n = 75) had no ASD restriction. Survival was determined for each group. Multivariate analysis was conducted to test risk factors for mortality.

Results Mean follow-up was 26.3 ± 24.1 months. Survival was 78.7% ± 4.2% at 30-month interval and onward after Norwood procedure for the whole cohort; it was 43.8% ± 10.0%, 91.7% ± 8.0%, and 77.3% ± 5.0% for Group 1, 2, and 3, respectively. The difference was significant between Group 1 and Group 2 and 3: p < 0.001. Survival was similar for Group 2 and Group 3: p = 0.45. Combination of restrictive ASD and mitral or aortic atresia was found to be the sole risk factor for early and late mortality (odds ratio: 3.5, 95% confidence interval: 1.8–7.1, p < 0.001).

Conclusion Restrictive ASD only affects survival of HLHS patients following Norwood procedure if it is associated with mitral or aortic atresia.

Keywords

hypoplastic left heart syndrome - outcomes - pulmonary vascular resistance/hypertension - Norwood procedure - restrictive atrial septal defect

• References

• 1 Grant CA, Robertson B. Microangiography of the pulmonary arterial system in “hypoplastic left heart syndrome”. Circulation 1972; 45 (2) 382-388
• 2 Rychik J, Rome JJ, Collins MH, DeCampli WM, Spray TL. The hypoplastic left heart syndrome with intact atrial septum: atrial morphology, pulmonary vascular histopathology and outcome. J Am Coll Cardiol 1999; 34 (2) 554-560
• 3 Marshall AC, van der Velde ME, Tworetzky W , et al. Creation of an atrial septal defect in utero for fetuses with hypoplastic left heart syndrome and intact or highly restrictive atrial septum. Circulation 2004; 110 (3) 253-258
• 4 Vlahos AP, Lock JE, McElhinney DB, van der Velde ME. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: outcome after neonatal transcatheter atrial septostomy. Circulation 2004; 109 (19) 2326-2330
• 5 Gossett JG, Rocchini AP, Lloyd TR, Graziano JN. Catheter-based decompression of the left atrium in patients with hypoplastic left heart syndrome and restrictive atrial septum is safe and effective. Catheter Cardiovasc Interv 2006; 67 (4) 619-624
• 6 Vida VL, Bacha EA, Larrazabal A , et al. Hypoplastic left heart syndrome with intact or highly restrictive atrial septum: surgical experience from a single center. Ann Thorac Surg 2007; 84 (2) 581-585 , discussion 586
• 7 Glatz JA, Tabbutt S, Gaynor JW , et al. Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg 2007; 84 (5) 1633-1638
• 8 Fishman A. Pulmonary hypertension. In: Robert C. Schlant (Ed.), Hurst's The Heart. 8th ed. New York: McGraw-Hill; 1994: 1857-1874
• 9 Photiadis J, Sinzobahamvya N, Hraška V, Asfour B. Does bilateral pulmonary banding in comparison to Norwood procedure improve outcome in neonates with hypoplastic left heart syndrome beyond second-stage palliation? A review of the current literature. Thorac Cardiovasc Surg 2012; 60 (3) 181-188
• 10 Photiadis J, Sinzobahamvya N, Haun C , et al. Does the shunt type determine mid-term outcome after Norwood operation?. Eur J Cardiothorac Surg 2012; 42 (2) 209-215 , discussion 215–216
• 11 Jenkins PC, Flanagan MF, Jenkins KJ , et al. Survival analysis and risk factors for mortality in transplantation and staged surgery for hypoplastic left heart syndrome. J Am Coll Cardiol 2000; 36 (4) 1178-1185
• 12 Photiadis J, Urban AE, Sinzobahamvya N , et al. Restrictive left atrial outflow adversely affects outcome after the modified Norwood procedure. Eur J Cardiothorac Surg 2005; 27 (6) 962-967
• 13 Hehir DA, Dominguez TE, Ballweg JA , et al. Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg 2008; 136 (1) 94-99 , e1–e3
• 14 Ohye RG, Sleeper LA, Mahony L , et al; Pediatric Heart Network Investigators. Comparison of shunt types in the Norwood procedure for single-ventricle lesions. N Engl J Med 2010; 362 (21) 1980-1992